Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.
Inflammation serves as a biological response to harmful stimuli, playing a crucial role in bodily defense but also leading to various chronic conditions ...